These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 20621282)

  • 21. Single-molecule fluorescence reveals sequence-specific misfolding in multidomain proteins.
    Borgia MB; Borgia A; Best RB; Steward A; Nettels D; Wunderlich B; Schuler B; Clarke J
    Nature; 2011 May; 474(7353):662-5. PubMed ID: 21623368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli.
    Wu W; Xing L; Zhou B; Lin Z
    Microb Cell Fact; 2011 Feb; 10():9. PubMed ID: 21320350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid-like properties of bacterial inclusion bodies.
    Carrió M; González-Montalbán N; Vera A; Villaverde A; Ventura S
    J Mol Biol; 2005 Apr; 347(5):1025-37. PubMed ID: 15784261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-pressure studies on protein aggregates and amyloid fibrils.
    Kim YS; Randolph TW; Seefeldt MB; Carpenter JF
    Methods Enzymol; 2006; 413():237-53. PubMed ID: 17046400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between the structural stability and aggregation propensity of proteins.
    Idicula-Thomas S; Balaji PV
    In Silico Biol; 2007; 7(2):225-37. PubMed ID: 17688448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein aggregation from inclusion bodies to amyloid and biomaterials.
    Mitraki A
    Adv Protein Chem Struct Biol; 2010; 79():89-125. PubMed ID: 20621282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloids in bacterial inclusion bodies.
    de Groot NS; Sabate R; Ventura S
    Trends Biochem Sci; 2009 Aug; 34(8):408-16. PubMed ID: 19647433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein aggregation: folding aggregates, inclusion bodies and amyloid.
    Fink AL
    Fold Des; 1998; 3(1):R9-23. PubMed ID: 9502314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards revealing the structure of bacterial inclusion bodies.
    Wang L
    Prion; 2009; 3(3):139-45. PubMed ID: 19806034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial Inclusion Bodies for Anti-Amyloid Drug Discovery: Current and Future Screening Methods.
    Caballero AB; Espargaró A; Pont C; Busquets MA; Estelrich J; Muñoz-Torrero D; Gamez P; Sabate R
    Curr Protein Pept Sci; 2019; 20(6):563-576. PubMed ID: 30924417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein aggregation and amyloid fibril formation prediction software from primary sequence: towards controlling the formation of bacterial inclusion bodies.
    Hamodrakas SJ
    FEBS J; 2011 Jul; 278(14):2428-35. PubMed ID: 21569208
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.